AI Generated Image
FDA approves new use of popular diabetes drug
Action News 5 • • business
Key Points:
- The FDA has approved the diabetes drug Mounjaro for expanded use to help prevent heart attacks and strokes in high-risk adults with type 2 diabetes.
- Mounjaro, produced by Eli Lilly, demonstrated an 8% greater reduction in major cardiovascular events compared to the older drug Trulicity.
- The medication is also marketed under the name Zepbound for weight loss treatment.
- Eli Lilly is currently developing new drugs aimed at targeting additional hormones to improve treatment outcomes.
